Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and pharmacodynamics of AZD4144 in participants with obesity. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AZD4144

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Participants | Phase 1 | Status: COMPLETED